| From: |
|
Alison Bunce - Medicines and Healthcare Products Regulatory Agency
|
|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Trusts (England) - Medical Director
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Clinical Commissioning Groups
- NHS Foundation Trusts (England) - Chief Executive
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Director of Public Health
- NHS Trusts (England) - Chief Executive
|
| Action category: |
|
Class 2: Action within 48 hours
|
| Title: |
|
DRUG ALERT CLASS 2, ACTION WITHIN 48 HOURS, B. BRAUN MEDICAL LIMITED, NUTRIFLEX OMEGA PLUS, NUTRIFLEX OMEGA SPECIAL, SUPPLEMENTED NUTRIFLEX OMEGA PLUS AND SUPPLEMENTED NUTRIFLEX OMEGA SPECIAL
|
| Broadcast content: |
|
Recall of certain batches of the above products as a precautionary measure because ongoing product monitoring has identified that some bags may not comply with the required specification throughout the product shelf-life.
Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts
|